|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||3.0500 - 3.3000|
|52-week range||3.0500 - 3.7000|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Key Insights Using the 2 Stage Free Cash Flow to Equity, AFT Pharmaceuticals fair value estimate is NZ$4.24 AFT...
Key Insights Insiders appear to have a vested interest in AFT Pharmaceuticals' growth, as seen by their sizeable...
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...